Zusammenfassung
Die Technik der späten Kontrastmittelanreicherung im MRT (delayed-enhancement [DE]-MRT) findet breite Anwendung in der klinischen Routine zur Beurteilung des Myokards. Myokarderkrankungen unterschiedlicher Ätiologie führen zu regionalen Veränderungen im Myokard wie Nekrose, Fibrose, Ödem oder Metaboliteinlagerungen, die mit der DE-MRT dargestellt werden können. Sowohl akute und chronische Myokardischämien auf dem Boden einer koronaren Herzerkrankung als auch nicht-ischämische Kardiomyopathien zeigen DE, häufig mit charakteristischem Anreicherungsmuster. Während das DE ischämischer Ursache subendokardial gelegen ist, zeigen nicht-ischämische Kardiomyopathien oft ein intramyokardiales oder subepikardiales Anreicherungsmuster. Das typische Muster dilatativer Kardiomyopathien ist eine bandförmige, intramyokardiale Anreicherung mit Beteiligung des Septums. Arrhythmogene rechtsventrikuläre Dysplasien/Kardiomyopathien gehen häufig mit einem rechtsventrikulären DE einher. Die kardiale Amyloidose als zumeist restriktive Kardiomyopathie zeigt typischerweise ein zirkuläres, subendokardiales DE. Hypertrophe Kardiomyopathien zeigen in den hypertrophierten Wandabschnitten ein fleckiges, intramyokardiales DE, welches typischerweise anteroseptal liegt. Akute Myokarditiden gehen unter Umständen mit einem intramyokardialen oder subepikardialen DE unter Einbeziehung der Seitenwand einher. Bei chronischen Myokarditiden kann vorwiegend intramyokardiales oder subepikardiales DE beobachtet werden. Bei kardialen Sarkoidosen wird ein fleckförmiges, subepikardiales Anreicherungsmuster mit rechts- und linksventrikulärer Beteiligung beschrieben. Überschneidungen der Anreicherungsmuster innerhalb der Kardiomyopathien bestehen jedoch, sodass die Trennschärfe allein anhand der DE-MRT beschränkt ist. Daher ist die DE-MRT immer in Zusammenschau mit anderen klinischen und MRT-Befunden zu bewerten. Vielfach korreliert die Menge an DE mit klinischen und funktionellen Parametern sowie mit der Häufigkeit an unerwünschten kardialen Ereignissen, sodass die DE-MRT möglicherweise zur Risikostratifizierung von Patienten geeignet ist. Weiterhin kann die DE-MRT zur Planung von Myokardbiopsien und zur Korrelation mit den Ergebnissen aus einer elektrophysiologischen Untersuchung eingesetzt werden.
Abstract
Contrast-enhanced MRI using the delayed-enhancement technique (DE-MRI) is widely applied in the clinical work-up of myocardial diseases. Myocardial diseases of varying etiology result in myocardial changes, such as necrosis, fibrosis, edema and metabolite deposition, which can be visualized by DE-MRI. Acute and chronic ischemic diseases based on a coronary artery disease as well as non-ischemic cardiomyopathies display DE. Cardiomyopathies often show a characteristic enhancement pattern. While ischemic lesions are localized in the subendocardium, non-ischemic cardiomyopathies often display an intramyocardial or subepicardial pattern. The typical pattern for dilated cardiomyopathies is band-like and intramyocardial with septal involvement. Arrhythmogenic right-ventricular dysplasias/cardiomyopathies are frequently associated with right-ventricular DE. In the case of amyloid cardiomyopathies which are often restrictive cardiomyopathies, subendocardial and circular DE is typically observed. Hypertrophic cardiomyopathies display patchy intramyocardial DE usually in the anteroseptal region. Acute myocarditis is typically accompanied by intramyocardial or subepicardial DE affecting the lateral wall. In the case of chronic myocarditis, intramyocardial or subepicardial DE is observed most frequently. Cardiac sarcoidosis typically entails patchy subepicardial DE with right- and left-ventricular involvement. Since there is an overlap between the enhancement patterns of cardiomyopathies, the diagnostic accuracy of DE-MRI is limited and the diagnosis must be based on additional clinical and MRI findings. The amount of DE often corresponds with cardiac functional parameters as well as with the frequency of cardiac events so that DE-MRI may be useful for risk stratification. Furthermore, DE-MRI can be helpful in the planning and evaluation of myocardial biopsies and electrophysiological examinations.
Key words
gadolinium - cardiac - tissue characterization - ischemia/infarction - infection
Literatur
1
Richardson P, McKenna W, Bristow M. et al .
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
Circulation.
1996;
93
841-842
2
Miller S, Riessen R.
MR-tomographische Diagnostik von Kardiomyopathien.
Fortschr Röntgenstr.
2005;
177
1497-1505
3
Gutberlet M, Spors B, Grothoff M. et al .
Vergleich verschiedener kardialer MRT-Sequenzen bei 1.5 T/3.0 T bezüglich des Signal- und Kontrast-zu-Rausch-Verhältnisses - Erste Erfahrungen.
Fortschr Röntgenstr.
2004;
176
801-808
4
Kramer U, Wolf S, Fenchel M. et al .
TrueFISP-MR-Bildgebung zur Bestimmung des Einflusses der Hamodialyse auf myokardiale Funktionsparameter bei Patienten mit terminaler Niereninsuffizienz.
Fortschr Röntgenstr.
2004;
176
350-356
5
Krombach G A, Spuentrup E, Buecker A. et al .
Herztumoren: Magnetresonanztomographie und Mehrschicht-Spiral-CT.
Fortschr Röntgenstr.
2005;
177
1205-1218
6
Friedrich M G, Strohm O, Schulz-Menger J. et al .
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis.
Circulation.
1998;
97
1802-1809
7
Rehr R B, Peshock R M, Malloy C R. et al .
Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration.
Am J Cardiol.
1986;
57
864-868
8
Simonetti O P, Kim R J, Fieno D S. et al .
An improved MR imaging technique for the visualization of myocardial infarction.
Radiology.
2001;
218
215-223
9
Kim R J, Fieno D S, Parrish T B. et al .
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.
Circulation.
1999;
100
1992-2002
10
Stork A, Lund G K, Bansmann M. et al .
Vergleich der ödemsensitiven HASTE-TIRM-Sequenz mit der späten Kontrastmittelanreicherung bei akutem Myokardinfarkt.
Fortschr Röntgenstr.
2003;
175
194-198
11
Stork A, Lund G K, Muellerleile K. et al .
Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction.
Eur Radiol.
2006;
16
2350-2357
12
Judd R M, Lugo-Olivieri C H, Arai M. et al .
Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts.
Circulation.
1995;
92
1902-1910
13
Saeed M, Lund G, Wendland M F. et al .
Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media.
Circulation.
2001;
103
871-876
14
Lund G K, Stork A, Saeed M. et al .
Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging.
Radiology.
2004;
232
49-57
15
Pennell D J, Sechtem U P, Higgins C B. et al .
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.
Eur Heart J.
2004;
25
1940-1965
16
Choi K M, Kim R J, Gubernikoff G. et al .
Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.
Circulation.
2001;
104
1101-1107
17
Haase J, Bayar R, Hackenbroch M. et al .
Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention.
J Interv Cardiol.
2004;
17
367-373
18
Ingkanisorn W P, Rhoads K L, Aletras A H. et al .
Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction.
J Am Coll Cardiol.
2004;
43
2253-2259
19
Selvanayagam J B, Kardos A, Nicolson D. et al .
Anteroseptal or apical myocardial infarction: a controversy addressed using delayed enhancement cardiovascular magnetic resonance imaging.
J Cardiovasc Magn Reson.
2004;
6
653-661
20
Bos E J, Baks T van den, Moelker A D. et al .
Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking?.
Eur Heart J.
2006;
27
1620-1626
21
Gerber B L, Rochitte C E, Melin J A. et al .
Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction.
Circulation.
2000;
101
2734-2741
22
Kim R J, Hillenbrand H B, Judd R M.
Evaluation of myocardial viability by MRI.
Herz.
2000;
25
417-430
23
Rochitte C E, Lima J A, Bluemke D A. et al .
Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.
Circulation.
1998;
98
1006-1014
24
Wu K C, Kim R J, Bluemke D A. et al .
Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion.
J Am Coll Cardiol.
1998;
32
1756-1764
25
Kim R J, Wu E, Rafael A. et al .
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
N Engl J Med.
2000;
343
1445-1453
26
Rominger M B, Bachmann G F, Geuer M. et al .
Comparison of left and right ventricular ejection and filling parameters of the heart using cine-MRI with breath holding technique. Clinical study of 42 patients with cardiomyopathy and coronary heart disease.
Fortschr Röntgenstr.
1999;
170
534-541
27
McCrohon J A, Moon J C, Prasad S K. et al .
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
Circulation.
2003;
108
54-59
28
Mollet N R, Dymarkowski S, Volders W. et al .
Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease.
Circulation.
2002;
106
2873-2876
29
Elliott P.
Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy.
Heart.
2000;
84
106-112
30
Zimmermann O, Grebe O, Merkle N. et al .
Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy.
Eur J Heart Fail.
2006;
8
162-166
31
Nazarian S, Bluemke D A, Lardo A C. et al .
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy.
Circulation.
2005;
112
2821-2825
32
Akisawa M, Matsumura Y, Kitaoka H. et al .
Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy.
J Cardiol.
2002;
40
145-152
33
Dec G W, Fuster V.
Idiopathic dilated cardiomyopathy.
N Engl J Med.
1994;
331
1564-1575
34
Menghetti L, Basso C, Nava A. et al .
Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy.
Heart.
1996;
76
467-470
35
Molinari G, Sardanelli F, Gaita F. et al .
Right ventricular dysplasia as a generalized cardiomyopathy? Findings on magnetic resonance imaging.
Eur Heart J.
1995;
16
1619-1624
36
Blake L M, Scheinman M M, Higgins C B.
MR features of arrhythmogenic right ventricular dysplasia.
AJR Am J Roentgenol.
1994;
162
809-812
37
Ricci C, Longo R, Pagnan L. et al .
Magnetic resonance imaging in right ventricular dysplasia.
Am J Cardiol.
1992;
70
1589-1595
38
Auffermann W, Wichter T, Breithardt G. et al .
Arrhythmogenic right ventricular disease: MR imaging vs angiography.
Am J Roentgenol.
1993;
161
549-555
39
Wall E E, Kayser H W, Bootsma M M. et al .
Arrhythmogenic right ventricular dysplasia: MRI findings.
Herz.
2000;
25
356-364
40
Pennell D van der, Casolo G.
Right ventricular arrhythmia: emergence of magnetic resonance imaging as an investigative tool.
Eur Heart J.
1997;
18
1843-1845
41
Midiri M, Finazzo M, Brancato M. et al .
Arrhythmogenic right ventricular dysplasia: MR features.
Eur Radiol.
1997;
7
307-312
42
Bluemke D A, Krupinski E A, Ovitt T. et al .
MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability.
Cardiology.
2003;
99
153-162
43
Tandri H, Bomma C, Calkins H. et al .
Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia.
J Magn Reson Imaging.
2004;
19
848-858
44
Aviram G, Fishman J E, Young M L. et al .
MR evaluation of arrhythmogenic right ventricular cardiomyopathy in pediatric patients.
Am J Roentgenol.
2003;
180
1135-1141
45
Cesare E di.
MRI assessment of right ventricular dysplasia.
Eur Radiol.
2003;
13
1387-1393
46
Tandri H, Calkins H, Nasir K. et al .
Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia.
J Cardiovasc Electrophysiol.
2003;
14
476-482
47
Tandri H, Saranathan M, Rodriguez E R. et al .
Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.
J Am Coll Cardiol.
2005;
45
98-103
48
Maceira A M, Joshi J, Prasad S K. et al .
Cardiovascular magnetic resonance in cardiac amyloidosis.
Circulation.
2005;
111
186-193
49
Perugini E, Rapezzi C, Piva T. et al .
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.
Heart.
2006;
92
343-349
50
Hunold P, Schlosser T, Vogt F M. et al .
Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease.
Am J Roentgenol.
2005;
184
1420-1426
51
Martin N, Ott R, Klues H G.
Idiopathic hypereosinophilia with cardiac involvement.
Dtsch Med Wochenschr.
2004;
129
557-560
52
Moon J C, Mogensen J, Elliott P M. et al .
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Heart.
2005;
91
1036-1040
53
Amano Y, Takayama M, Takahama K. et al .
Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
J Magn Reson Imaging.
2004;
20
595-600
54
Teraoka K, Hirano M, Ookubo H. et al .
Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
Magn Reson Imaging.
2004;
22
155-161
55
Bogaert J, Goldstein M, Tannouri F. et al .
Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging.
Am J Roentgenol.
2003;
180
981-985
56
Moon J C, McKenna W J, McCrohon J A. et al .
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.
J Am Coll Cardiol.
2003;
41
1561-1567
57
Choudhury L, Mahrholdt H, Wagner A. et al .
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
J Am Coll Cardiol.
2002;
40
2156-2164
58
Kuribayashi T, Roberts W C.
Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
Am J Cardiol.
1992;
70
1333-1340
59
Maron B J, Epstein S E, Roberts W C.
Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.
Am J Cardiol.
1979;
43
1086-1102
60
Maron B J, Wolfson J K, Epstein S E. et al .
Intramural („small vessel”) coronary artery disease in hypertrophic cardiomyopathy.
J Am Coll Cardiol.
1986;
8
545-557
61
Varnava A M, Elliott P M, Sharma S. et al .
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.
Heart.
2000;
84
476-482
62
Moon J C, Reed E, Sheppard M N. et al .
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
J Am Coll Cardiol.
2004;
43
2260-2264
63
Kim R J, Judd R M.
Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?.
J Am Coll Cardiol.
2003;
41
1568-1572
64
Mahrholdt H, Goedecke C, Wagner A. et al .
Multimedia article. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.
Circulation.
2004;
109
1250-1258
65
Rieker O, Mohrs O, Oberholzer K. et al .
MRT des Herzens bei Verdacht auf Myokarditis.
Fortschr Röntgenstr.
2002;
174
1530-1536
66
Laissy J P, Hyafil F, Feldman L J. et al .
Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging.
Radiology.
2005;
237
75-82
67
Abdel-Aty H, Boye P, Zagrosek A. et al .
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.
J Am Coll Cardiol.
2005;
45
1815-1822
68
De Cobelli F, Pieroni M, Esposito A. et al .
Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias.
J Am Coll Cardiol.
2006;
47
1649-1654
69
Nemeth M A, Muthupillai R, Wilson J M. et al .
Cardiac sarcoidosis detected by delayed-hyperenhancement magnetic resonance imaging.
Tex Heart Inst J.
2004;
31
99-102
70
Serra J J, Monte G U, Mello E S. et al .
Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging.
Circulation.
2003;
107
e188-189
71
Vignaux O.
Cardiac sarcoidosis: spectrum of MRI features.
Am J Roentgenol.
2005;
184
249-254
Dr. Alexander Stork
Klinik und Poliklinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Hamburg-Eppendorf
Martinistraße 52
20246 Hamburg
Phone: ++49/40/4 28 03 40 10
Fax: ++49/40/4 28 03 67 99
Email: a.stork@uke.uni-hamburg.de